Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone

Manufacturer
Wal-Mart Stores Inc. | Solskyn Personal Care LLC | Accra Pac, Inc.
Effective date
2019-06-26
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:59:46

Label at a glance#

ProductAvobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone
Active ingredientAVOBENZONE, OCTISALATE, OCTOCRYLENE, OXYBENZONE, HOMOSALATE
Label structure13 sections

Indications and uses

• Helps prevent sunburn • If used as directed with other sun protection measure (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.

Dosage and administration

Apply liberally 15 minutes before sun exposure. • after 80 minutes of swimming or sweating • immediately after towel drying Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with broad spectrum of SPF of 15 or higher and other sun protection measures including: • limit time in the sun, especially 10a.m.-2a.m. ...

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 2.8% Oxybenzone 6%

Purpose

OTC - PURPOSE SECTION

Sunscreen

Uses

INSTRUCTIONS FOR USE SECTION

• Helps prevent sunburn • If used as directed with other sun protection measure (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

Do not use on damaged or broken skin.

When using this product

OTC - WHEN USING SECTION

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor

OTC - ASK DOCTOR SECTION

Stop use and ask a doctor if rash occurs.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

INSTRUCTIONS FOR USE SECTION

Apply liberally 15 minutes before sun exposure.

• after 80 minutes of swimming or sweating

• immediately after towel drying

Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with broad spectrum of SPF of 15 or higher and other sun protection measures including:

• limit time in the sun, especially 10a.m.-2a.m.

• wear long-sleeved shirts, pants, hats and sunglasses

•Children under 6 months: ask a doctor

Other Information

OTHER SAFETY INFORMATION

• Protect the product in this container from excessive heat and direct sun

• May stain some fabrics and surfaces

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water, Acrylates Copolymer, Styrene/Acrylates Copolymer, Butyl Octyl Salicylate, Tapioca Starch, Neopentyl Glycol Diheptanoate, Silica, Glyceryl Stearate, PEG-100 Stearate, Behenyl Alcohol, Caprylyl Glycol, Diethylhexyl 2,6-Napthalate, Polyester-7, Beeswax, Fragrance, Phenoxyethanol, Potassium Hydroxide, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Sodium Polyacrylate, Polymethylsilsesquioxane, Disodium EDTA

Questions

OTC - QUESTIONS SECTION

Satisfaction guaranteed - For questions or comments please call 1-888-287-1915.

DISTRIBUTED BY: Walmart Inc.,

Bentonville, AR 72716

*This product is not manufactured or distributed by Johnson and Johnson Corporation,m owner of the registered trademarks Neutrogena® and Neutrogena Ultra Sheer®

PKTB-41429-WM01

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

equate TM beauty

Compare to NEUTROGENA® ULTRA SHEER®

DRY-TOUCH SUNSCREEN*

heer

Sunscreen

LOTION

SPF

70

Broad Spectrum SPF 70

UVA/UVB protection

Dermatologist tested

Water resistant up to 80 minutes

Oil-free • Lightweight • Clean feel

PARABEN FREE

6 FL OZ (177mL)

Private Label Equate Beauty Ultra Sheer SPF 70 LabelPrivate Label Equate Beauty Ultra Sheer SPF 70 Label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
777d68c6-a5ab-e06c-d314-677b0b9af0c8Product name220240508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
49035-406-062023-01-30C16284748780-1f386c64a-21a9-0266-e053-dadaa90a7c1aPrivate Label Equate Beauty Ultra Sheer Sunscreen SPF 70

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49035-406-06Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone177 g in 1 CONTAINERLOTION1772

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
49035-406AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE (EQUATE BEAUTY ULTRA SHEER SPF 70) LOTION [WAL-MART STORES INC.]2Legacy NDC, 1 package rows20190627_87aef5d4-860d-7d44-e053-2a95a90aaaea.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 26 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49035-40649035-406-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
8c409e81-dae6-dc1a-e053-2995a90a5e9887aef5d4-860d-7d44-e053-2a95a90aaaea2019-06-26WarningsExact identifier
spl id: 8c409e81-dae6-dc1a-e053-2995a90a5e98
spl set id: 87aef5d4-860d-7d44-e053-2a95a90aaaea

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.